Survey on the current status of treatment of subjective symptoms and the use of topical agents in patients receiving therapy for plaque psoriasis

Survey on the current status of treatment of subjective symptoms and the use of topical agents in patients receiving therapy for plaque psoriasis - Survey on the current status of treatment of subjective symptoms and the use of topical agents in patients receiving therapy for plaque psoriasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016257

Enrollment

1000

Registered

2015-01-19

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis vulgaris

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients aged 20 years or older who are diagnosed with plaque psoriasis - Patients who are scheduled to start at least 4 weeks of treatment with a topical compound consisting of active vitamin D3 and steroid or who are currently treated with the compound

Exclusion criteria

Exclusion criteria: - Patients without plaque psoriasis - Patients under the age of 20 years - Patients who are not scheduled to be treated with a topical compound consisting of active vitamin D3 and steroid

Design outcomes

Primary

Measure	Time frame
- Treatment strategies for plaque psoriasis - Satisfaction with treatment	—

Countries

Japan

Contacts

Public ContactEri Muto

QOL RD Co.,Ltd. Clinical Development Group 1 CRO Department Drug Division

tsgp-study@qol-rd.co.jp03-6386-8801

Outcome results